Industrials

The global Excipients Market, valued at $7.8 Billion in 2024, is projected to reach $10.2 Billion by 2030, growing at a CAGR of 4.6%. This comprehensive report analyzes key trends, drivers, and forecasts, emphasizing the essential role of excipients in pharmaceutical formulations. Discover how excipients enhance drug efficacy and patient experience, explore innovations like multifunctional excipients, and gain insights into regional growth trends, notably in the U.S. and China.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Prepaid Gift Card Market size & share revenue was valued at approximately USD 2.7 Billion in 2024 and is expected to reach USD 2.91 Billion in 2025 and is expected to reach around USD 5.41 Billion by 2034, at a CAGR of 7.1% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Kaiku Finance LLC, Green Dot Corporation, Bank of America Corporation, The PNC Financial Services Group Inc., J.P. Morgan Chase & Co., CAIXABANK S.A., DFS Services LLC, The Points Guy LLC, BlackHawk Network Holdings Inc., Travelex Foreign Coin Services Limited, RBL Bank Ltd., PayPal Holdings Inc., Visa Inc., City Bank PLC, NetSpend Corporation, Mango Financial Inc., HRB Digital LLC., Western Union Holdings, Mastercard & Others.

The global Nutraceutical Excipients market is expected to grow from USD 5 billion in 2024 to USD 7.2 billion by 2030, at a CAGR of 6.2%. Key trends driving this market include a shift towards clean-label, organic excipients and technological advances like nanotechnology that enhance ingredient bioavailability. This report offers comprehensive insights into market trends, regional growth projections, and strategic opportunities, identifying major players such as ABF Ingredients and Cargill. Explore detailed regional analyses and future market insights to inform strategic decisions.

Discover the thriving AI-Enabled Drug Discovery and Clinical Trials Market set to exceed USD 3 billion by 2025, with projections extending to 2035. Key growth drivers include accelerated drug development timelines and cost efficiency through AI innovations such as generative models and predictive analytics. Despite challenges like regulatory compliance and data integration, the report highlights lucrative investment areas and regional market forecasts. Gain insights into market dynamics, competitive landscapes, and strategic opportunities to stay ahead in this evolving industry.

The global Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market is set to exceed USD 20 billion by 2025, driven by rising geopolitical tensions and technological innovations in threat detection and defense systems. Get insights into major players, market trends, and regional forecasts up to 2035. Discover how AI and miniaturized detection devices are enhancing military and emergency response capabilities. This comprehensive report provides essential knowledge for companies seeking growth and new revenue streams in this dynamic market.

Biogas Outlook 2025: With 105 billion tonnes of organic waste produced annually and 98% untreated, biogas offers a viable clean energy solution. Challenges include high capital costs and policy uncertainty. Sector growth is notable at 19% (2017-2022), but accelerated progress is crucial to meet 2030 targets.

Disclosure of trading in own shares occurred
from June 2 to June 6, 2025

Déclaration des transactions sur actions propres réalisées
du 2 juin au 6 juin 2025

Lassila & Tikanoja plc
Inside information
9 June 2025 at 9:00 a.m.

Amsterdam, 9 June 2025 --- AMG Critical Materials N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") is pleased to announce that Mr. Thomas Swoboda has been appointed the new global Head of Investor Relations, effective immediately. He is the successor to Ms. Michele Fischer, who has held that position for the last six years and has transitioned to Head of Human Resources on a global level as Executive Vice President.